Poor Glycaemic Control in Type 2 Diabetes Compromises Leukocyte Oxygen Consumption Rate, OXPHOS Complex Content and Neutrophil-endothelial Interactions

Overview

Journal Redox Biol

Specialties Biology
Cell Biology
Endocrinology

Date 2025 Feb 22

PMID 39986115

Authors

Julia Cacace

Clara Luna-Marco

Alberto Hermo-Argibay

Catherine Pesantes-Somogyi

Omar A Hernandez-Lopez

Maria Pelecha-Salvador

Celia Banuls

Nadezda Apostolova

Luis de Miguel-Rodriguez

Carlos Morillas

Milagros Rocha

Susana Rovira-Llopis

Victor M Victor

Affiliations

Soon will be listed here.

Abstract

The mitochondrial electron transport chain becomes overloaded in type 2 diabetes (T2D), which increases ROS (Reactive Oxygen Species) production and impairs mitochondrial function. Peripheral blood mononuclear cells (PBMCs) are critical players in the inflammatory process that underlies T2D. Poor glycaemic control in T2D is closely linked to the development of comorbidities. Our aim was to evaluate if glycaemic control in T2D has an impact on the oxygen consumption rates (OCR) of PBMC, OXPHOS complexes and inflammation. We recruited 181 subjects, consisting of 79 healthy controls, 64 patients with T2D and good glycaemic control (HbA1c<7 %), and 38 T2D patients with poor glycaemic control (HbA1c>7 %). We found a decrease in the basal OCR of PBMCs from patients with HbA1c>7 % with respect to controls (p < 0.05). Maximal OCR and spare respiratory capacity were lower in patients with HbA1c>7 % than in controls and patients with HbA1c<7 % (p < 0.05 for all). Mitochondrial ROS levels were higher in T2D patients, and particularly in the HbA1c > 7 group (p < 0.05 HbA1c<7 % vs control, p < 0.001 HbA1c>7 % vs control; p < 0.001 HbA1c > 7 vs HbA1c < 7). With respect to controls, poor glycaemic control in T2D patients was associated with a decrease in mitochondrial complex III and V (p < 0.05 and p < 0.01, respectively) and enhanced neutrophil-endothelial interactions (p < 0.001 vs controls). MPO levels were enhanced in T2D patients in general (p < 0.05 vs controls), and ICAM-1 and VCAM-1 were specifically increased in HbA1c > 7 patients vs controls (p < 0.01 and p < 0.001, respectively). Negative low-to-moderate correlations were found between HbA1c and basal respiration (r = -0.319, p < 0.05), maximal respiration (r = -0.350, p < 0.01) and spare respiratory capacity (r = -0.295, p < 0.05). Our findings suggest that poor glycaemic control during the progression of T2D compromises mitochondrial respiration and OXPHOS complex content in PBMCs. These alterations occur in parallel to enhanced neutrophil-endothelial interactions and adhesion molecule levels, leaving T2D patients with poor glycaemic control at a higher risk of developing vascular diseases.

References

Hartman M, Shirihai O, Holbrook M, Xu G, Kocherla M, Shah A . Relation of mitochondrial oxygen consumption in peripheral blood mononuclear cells to vascular function in type 2 diabetes mellitus. Vasc Med. 2014; 19(1):67-74. PMC: 3932629. DOI: 10.1177/1358863X14521315. View

Braganza A, Annarapu G, Shiva S . Blood-based bioenergetics: An emerging translational and clinical tool. Mol Aspects Med. 2019; 71:100835. PMC: 7031032. DOI: 10.1016/j.mam.2019.100835. View

Skoog T, Dichtl W, Boquist S, Skoglund-Andersson C, Karpe F, Tang R . Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J. 2002; 23(5):376-83. DOI: 10.1053/euhj.2001.2805. View

Hernandez-Mijares A, Rocha M, Rovira-Llopis S, Banuls C, Bellod L, de Pablo C . Human leukocyte/endothelial cell interactions and mitochondrial dysfunction in type 2 diabetic patients and their association with silent myocardial ischemia. Diabetes Care. 2013; 36(6):1695-702. PMC: 3661843. DOI: 10.2337/dc12-1224. View

Petersen K, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman D . Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003; 300(5622):1140-2. PMC: 3004429. DOI: 10.1126/science.1082889. View

Czajka A, Ajaz S, Gnudi L, Parsade C, Jones P, Reid F . Altered Mitochondrial Function, Mitochondrial DNA and Reduced Metabolic Flexibility in Patients With Diabetic Nephropathy. EBioMedicine. 2015; 2(6):499-512. PMC: 4534759. DOI: 10.1016/j.ebiom.2015.04.002. View

Rovira-Llopis S, Rocha M, Falcon R, de Pablo C, Alvarez A, Jover A . Is myeloperoxidase a key component in the ROS-induced vascular damage related to nephropathy in type 2 diabetes?. Antioxid Redox Signal. 2013; 19(13):1452-8. PMC: 3797450. DOI: 10.1089/ars.2013.5307. View

Larsen M, Horder M, MOGENSEN E . Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. N Engl J Med. 1990; 323(15):1021-5. DOI: 10.1056/NEJM199010113231503. View

Canet F, Diaz-Pozo P, Luna-Marco C, Fernandez-Reyes M, Vezza T, Marti M . Mitochondrial redox impairment and enhanced autophagy in peripheral blood mononuclear cells from type 1 diabetic patients. Redox Biol. 2022; 58:102551. PMC: 9713367. DOI: 10.1016/j.redox.2022.102551. View

10.

Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R . Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation. 1997; 95(7):1783-90. DOI: 10.1161/01.cir.95.7.1783. View

11.

Dupre-Crochet S, Erard M, NuBe O . ROS production in phagocytes: why, when, and where?. J Leukoc Biol. 2013; 94(4):657-70. DOI: 10.1189/jlb.1012544. View

12.

Lemasters J . Variants of mitochondrial autophagy: Types 1 and 2 mitophagy and micromitophagy (Type 3). Redox Biol. 2014; 2:749-54. PMC: 4085350. DOI: 10.1016/j.redox.2014.06.004. View

13.

Luc K, Schramm-Luc A, Guzik T, Mikolajczyk T . Oxidative stress and inflammatory markers in prediabetes and diabetes. J Physiol Pharmacol. 2020; 70(6). DOI: 10.26402/jpp.2019.6.01. View

14.

Wang D, Naumova A, Isquith D, Sapp J, Huynh K, Tucker I . Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure. Cardiovasc Diabetol. 2024; 23(1):197. PMC: 11161924. DOI: 10.1186/s12933-024-02294-z. View

15.

Pettersson U, Christoffersson G, Massena S, Ahl D, Jansson L, Henriksnas J . Increased recruitment but impaired function of leukocytes during inflammation in mouse models of type 1 and type 2 diabetes. PLoS One. 2011; 6(7):e22480. PMC: 3143146. DOI: 10.1371/journal.pone.0022480. View

16.

Croston T, Thapa D, Holden A, Tveter K, Lewis S, Shepherd D . Functional deficiencies of subsarcolemmal mitochondria in the type 2 diabetic human heart. Am J Physiol Heart Circ Physiol. 2014; 307(1):H54-65. PMC: 4080178. DOI: 10.1152/ajpheart.00845.2013. View

17.

Luna-Marco C, de Maranon A, Hermo-Argibay A, Rodriguez-Hernandez Y, Hermenejildo J, Fernandez-Reyes M . Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes. Redox Biol. 2023; 66:102849. PMC: 10457591. DOI: 10.1016/j.redox.2023.102849. View

18.

Rovira-Llopis S, Banuls C, Apostolova N, Morillas C, Hernandez-Mijares A, Rocha M . Is glycemic control modulating endoplasmic reticulum stress in leukocytes of type 2 diabetic patients?. Antioxid Redox Signal. 2014; 21(12):1759-65. DOI: 10.1089/ars.2014.6030. View

19.

Nishikawa T, Edelstein D, Du X, Yamagishi S, Matsumura T, Kaneda Y . Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000; 404(6779):787-90. DOI: 10.1038/35008121. View

20.

Gonzalez F, Rote N, Minium J, Kirwan J . Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2005; 91(1):336-40. DOI: 10.1210/jc.2005-1696. View